We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current CMRA market cap is 307.38k. The company's latest EPS is USD -0.5979 and P/E is -0.07.
Year End December 30 2022 | 2021 | 2022 |
---|---|---|
USD (US$) | USD (US$) | |
Total Revenue | 320k | 633k |
Operating Income | -6.59M | -11.97M |
Net Income | -802k | -18.38M |
Year End December 30 2022 | 2021 | 2022 |
---|---|---|
USD (US$) | USD (US$) | |
Total Assets | 9.65M | 3.73M |
Total Liabilities | 4.33M | 5.46M |
Total Equity | 5.32M | -6.25M |
Year End December 30 2022 | 2021 | 2022 |
---|---|---|
USD (US$) | USD (US$) | |
Operating | N/A | -9.77M |
Investing | N/A | -29k |
Financing | N/A | 5.24M |
Market Cap | 307.38k |
Price to Earnings Ratio | -0.07 |
Price to Sales Ratio | 1.94 |
Price to Cash Ratio | 2.76 |
Price to Book Ratio | -0.71 |
Dividend Yield | - |
Shares Outstanding | 30.74M |
Average Volume (1 week) | 16.99k |
Average Volume (1 Month) | 11.33k |
52 Week Change | -66.67% |
52 Week High | 0.128 |
52 Week Low | 0.000001 |
Spread (Intraday) | 0 (0%) |
Company Name | Comera Life Sciences Holdings Inc (CE) |
Address |
1521 concord pike suite 201 wilmington, delaware 19803 |
Website | https://comeralifesciences.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions